Neil Khoury, MD Profile
Neil Khoury, MD

@NeilKhouryMD

Followers
897
Following
247
Statuses
123

Chief GI Fellow @UConnGI | Internal medicine trained at NewYork-Presbyterian Brooklyn Methodist - views are my own

Joined September 2023
Don't wanna be here? Send us removal request.
@NeilKhouryMD
Neil Khoury, MD
1 day
Proposed algorithm for Resmetirom use for MASLD w/ F2-3 fibrosis, courtesy of @AmJGastro 💊Prescribing considerations: - 80mg qd dosing - ⬆️ to 100mg if wt 100kg+ - ⬇️ to 60mg if pt on Plavix - Avoid if pt on Gemfibrozil - Limit concurrent statin dosing (atorva 40, rosuva 20)
Tweet media one
0
43
105
@NeilKhouryMD
Neil Khoury, MD
18 days
RT @AmerGastroAssn: 📢 New guideline: Learn how to prevent and manage hepatitis B reactivation in patients on immunosuppressive drugs. Read…
0
33
0
@NeilKhouryMD
Neil Khoury, MD
18 days
RT @UConnGI: We had an excellent GI Grand Rounds lecture on “Sex Differences in Digestive Diseases: Endometriosis and Its Gut Connection” 💩…
0
3
0
@NeilKhouryMD
Neil Khoury, MD
19 days
RT @ebtapper: Read this A review of reported adverse events for medications to treat alcohol use disorder From @doc_sooyoung we must…
0
15
0
@NeilKhouryMD
Neil Khoury, MD
23 days
@KMonkemuller This appears to be the second portion of the duo so the orientation should be slightly different than the bulb orientation that we are familiar with for describing duo bulb ulcers (since the second portion dips downwards). Perhaps @AmerGastroAssn can weigh in 🙂
1
0
2
@NeilKhouryMD
Neil Khoury, MD
23 days
🙏🙏
@ebtapper
Elliot Tapper
24 days
Medicare planning to negotiate prices for rifaximin After 15-16 years of decrying the cost, there is hope for hepatologists
Tweet media one
0
1
1
@NeilKhouryMD
Neil Khoury, MD
23 days
Diet elimination therapy options and respective efficacy ranges, courtesy of the #2025 #ACG #EoE Clinical Guideline 💡Key concept: Providers may consider starting with a less-restrictive empiric elimination (i.e., 1FED or 2FED) as the initial diet therapy choice. 🚫🥛 = 🙂!
Tweet media one
0
6
23
@NeilKhouryMD
Neil Khoury, MD
23 days
FDA Approves First Medication for Obstructive Sleep Apnea Tirzepatide, a GLP-1 agonist, is now FDA approved for moderate to severe OSA in adults with obesity. Based on data from 2 RCTs that showed improved AHI from baseline. Good to know for #MASLD pts
1
2
12
@NeilKhouryMD
Neil Khoury, MD
25 days
RT @AmerGastroAssn: Get practical tips for implementing AI 🤖 in clinical workflows and understand its use as a research tool and emerging e…
0
4
0
@NeilKhouryMD
Neil Khoury, MD
28 days
RT @JHashashMD: 🔥🔊@AmerGastroAssn Clinical Practice Update on Healthcare Maintenance in #IBD @AGA_CGH @dr_fcalderaibd @SunandaKaneMD and @…
0
59
0
@NeilKhouryMD
Neil Khoury, MD
2 months
Anyone else have festive endoscopy white board art? 🙂🎅🏼 #GITwitter
Tweet media one
0
0
5
@NeilKhouryMD
Neil Khoury, MD
2 months
RT @NFL: Proud to stand with the @BuffaloBills, @HamlinIsland and @American_Heart in support of the HEARTS Act, which will provide lifesavi…
0
154
0
@NeilKhouryMD
Neil Khoury, MD
2 months
Snow day scoping squad 🫡 @UConnGI #GITwitter
Tweet media one
0
2
70
@NeilKhouryMD
Neil Khoury, MD
2 months
RT @UConnGI: Welcome to the family 🎉
Tweet media one
0
7
0
@NeilKhouryMD
Neil Khoury, MD
2 months
RT @UConnGI: Getting festive in the UConn GI documentation room 🌲
Tweet media one
0
2
0
@NeilKhouryMD
Neil Khoury, MD
3 months
Several promising blood-based biomarkers/panels are in various phases of validation. GALAD is furthest along. Shows promise for 📈 sensitivity for early stage HCC detection and likely increased adherence to surveillance! Potential to reduce mortality in HCC 🙏 @AmJGastro
Tweet media one
1
12
26
@NeilKhouryMD
Neil Khoury, MD
3 months
Ultrasound has low sensitivity for early HCC detection alone & 63% w/ AFP HCC 5-year survival is >70% for early-stage HCC vs. <10% for advanced stages. Can blood-based biomarkers (other than AFP) help w/ early detection? 🤔 @AmJGastro #LiverTwitter
Tweet media one
1
4
33
@NeilKhouryMD
Neil Khoury, MD
3 months
RT @UConnGI: Proud of our PGY4 GI Fellow Karthik for being highlighted in the GME Fall Newsletter 👏 #FellowSpotlight #GITwitter https://t.…
0
2
0